Neuroscience

Study uncovers key differences among ALS patients

Researchers on Mayo Clinic's Florida campus have identified key differences between patients with sporadic amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and those with the most common genetic form of ALS, a ...

Neuroscience

Discovery of the role of a key gene in the development of ALS

Amyotrophic lateral sclerosis, or ALS, attacks nerve cells known as motor neurons in the brain and spinal cord, gradually leading to paralysis. The loss of function of an important gene, C9orf72, may affect communication ...

Neuroscience

Researchers develop strategy to combat genetic ALS, FTD

A team of researchers at Mayo Clinic and The Scripps Research Institute in Florida have developed a new therapeutic strategy to combat the most common genetic risk factor for the neurodegenerative disorders amyotrophic lateral ...

Neuroscience

Smoking tied to shorter survival with ALS

(HealthDay)—Smoking may speed progression of Lou Gehrig's disease and shorten the lives of those with the fatal illness, new research suggests.

page 40 from 40